
All Products are stable to be shipped at room temperature, unless otherwise specified.
Pack Size | Quantity | Price (USD) | Sub Total |
---|---|---|---|
1mg | $ 50.00 | 0.0 | |
2mg | $ 90.00 | 0.0 | |
5mg | $ 150.00 | 0.0 | |
50mg | $ 990.00 | 0.0 | |
Exact Weight Packaging | $ 145.00 | 0.0 | |
Total | $ 0.0 |
Product successfully added to cart.
- Request another packsize ? Click here.
- Inventory Status : In Stock
- Ships On :
F335400
Bulk Order Request for F335400
Product Description
Catalogue Number | F335400 |
Chemical Name | Fidaxomicin |
Synonyms | (3E,5E,8S,9E,11S,12R,13E,15E,18S)-3-[[[6-Deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-β-D-mannopyranosyl]oxy]methyl]-12-[[6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-β-D-lyxo-hexopyranosyl]oxy]-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-oxacyclooctadeca-3,5,9,13,15-pentaen-2-one; |
CAS Number | 873857-62-6 |
Molecular Formula | C₅₂H₇₄Cl₂O₁₈ |
Appearance | White to Off-White Solid |
Melting Point | >160°C (dec.) |
Molecular Weight | 1058.04 |
Storage | 4°C |
Solubility | Chloroform (Slightly, Heated), DMSO (Slightly, Heated), Methanol (Slightly) |
Category | Standards; Chiral Molecules; Enzyme Activators and Inhibitors; Others; Pharmaceutical/API Drug Impurities/Metabolites; Antibotics; |
Applications | Fidaxomicin is a nonabsorbed macrocyclic antibiotic, and is the first antimicrobial to be approved by the FDA for the treatment of Clostridium difficile infection (CDI) in 20 years. Fidaxomicin works by inhibiting sporulation by CDI, sustaining clinical response and reducing recurrences of this pathogen. |
References | Babakhani, F., et al.: Clin. Infect. Dis., 55, S162 (2012); Venugopal, A., et al.: Clin. Infect. Dis., 54, 568 (2012) |